|
|
| MRD / Regn No. |
: 20250000739 |
Date |
: 05/06/2026 |
| Patient Name |
: Ambika Rajendran |
Age & Gender |
: 57 Yrs. / Female |
| Contact No. |
: 9840030566 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (23/Sep/2010) | ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (23/Sep/2009) | A2G2 DKD (23/Sep/2025) | |
|
Subjective |
: |
TYPE 2 DM FOR 15 YEARS,CURRENTLY ON OHAS,ASCVD SINCE 2009
|
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,ATHEROSCLEROTIC CARDIOVASCULAR DISEASE,A2G2 DKD |
|
Plan |
: |
RESTART GLP1RA,CHANGE DEG ASP TO 24-0-12 UNITS,CONTINUE SGLT2I,HOLD ARB,REST OF MEDICATIONS PER DR ABRAHAM OOMAN |
|
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION SEMAGLUTIDE 0.25 MG
OZEMPIC
Medicine For DM HEART KIDNEY PROTECTION |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
|
| MAY CAUSE NAUSEA OR VOMITING | |
|
2 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
0-18-0 UNITS |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
3 |
SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GENITOURINARY INFECTIONS | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 05/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |